AGMB
Agomab Therapeutics
$12.51
$0.00 (0%)Jul 27, 2026
Key metrics
The numbers that frame AGMB today
- Market cap
- $609.70M
- P/E (TTM)
- -8.4
- EV / FCF
- -8.5
- ROIC
- -629.6%
- Div yield
- 0%
- Debt / equity
- 0.0
Growth
Revenue and earnings trend for AGMB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AGMB
Is Agomab Therapeutics a good buy?
No. Agomab Therapeutics has poor quality. We think Agomab Therapeutics is selling at a very high price.
What is the market capitalization of AGMB?
Agomab Therapeutics's market capitalization is $609.70M.
What is the P/E ratio for AGMB stock?
Agomab Therapeutics's current P/E ratio is -8.4.
Does AGMB stock pay dividends?
Agomab Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AGMB?
Agomab Therapeutics's Debt / Equity ratio is 0.01.